PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34106748-12	2021	4-HPR (also known as fenretinide) is an inhibitor of DES1 and it exhibits antitumor activity and suppresses cell-cell fusion and viral infection.	Fenretinide	0-5	delta 4-desaturase, sphingolipid 1	Homo sapiens	53-57	
34106748-3	2021	N-(4-hydroxyphenyl) retinamide (4-HPR), an inhibitor of dihydroceramide Delta4-desaturase 1 (DES1), suppressed cell-cell fusion, and viral infection.	Fenretinide	0-30	delta 4-desaturase, sphingolipid 1	Homo sapiens	93-97	
34106748-3	2021	N-(4-hydroxyphenyl) retinamide (4-HPR), an inhibitor of dihydroceramide Delta4-desaturase 1 (DES1), suppressed cell-cell fusion, and viral infection.	Fenretinide	32-37	delta 4-desaturase, sphingolipid 1	Homo sapiens	93-97	
34106748-12	2021	4-HPR (also known as fenretinide) is an inhibitor of DES1 and it exhibits antitumor activity and suppresses cell-cell fusion and viral infection.	Fenretinide	21-32	delta 4-desaturase, sphingolipid 1	Homo sapiens	53-57	
31631013-4	2019	Inhibition of DEGS1 in hematopoietic stem and progenitor cells during the transition from quiescence to cellular activation with N-(4-hydroxyphenyl) retinamide activates coordinated stress pathways that coalesce on endoplasmic reticulum stress and autophagy programs to maintain immunophenotypic and functional HSCs.	Fenretinide	129-159	delta 4-desaturase, sphingolipid 1	Homo sapiens	14-19	
29500274-8	2018	Complementary experiments in these animal models using the DES1 inhibitor fenretinide show more modest effects on cone recovery.	Fenretinide	74-85	delta 4-desaturase, sphingolipid 1	Homo sapiens	59-63	
28448568-0	2017	Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets beta-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Delta4-desaturase 1.	Fenretinide	22-33	delta 4-desaturase, sphingolipid 1	Homo sapiens	247-260	
26934645-3	2016	These effects are recapitulated by the dihydroceramide desaturase (Des1) inhibitor, fenretinide.	Fenretinide	84-95	delta 4-desaturase, sphingolipid 1	Homo sapiens	67-71